Stocks Soar on Positive Trial Data and Other Catalysts
- DYN stock is rocketing over 122% on positive clinical trial data
- TPHS shares are soaring 115% on forbearance news
- SASI stock is surging 56% with strong early morning trading
- CREV shares are rising over 32%
- AGIO stock is increasing by over 31% on Phase 3 clinical trial data